La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease.
VL Villemagne, S Ng, R Cappai, KJ Barnham, MT Fodero-Tavoletti, CC Rowe, CL Masters
Neuroradiol J | Published : 2006
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterised by the gradual onset of dementia. The pathological hallmarks of the disease are Aβ amyloid plaques, neurofibrillary tangles (NFT), synaptic loss and reactive gliosis. Current diagnosis of AD is made by clinical, neuropsychologic, and neuroimaging assessments. Routine structural neuroimaging evaluation with computed tomography (CT) and magnetic resonance imaging (MRI) is based on non-specific features such as atrophy, a late feature in the progression of the disease, hence the crucial importance of developing new approaches for early and specific recognition at the prodromal stages of AD. Functional neuroimagin..View full abstract